Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review

Radiotherapy and Oncology

Volumn 90, Issue 1, 2009, Pages 1-13

  Offersen, Birgitte V ^a   Overgaard, Marie ^a   Kroman, Niels ^b   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Accelerated partial breast irradiation; Adjuvant radiotherapy; Early breast cancer

Indexed keywords

TAMOXIFEN;

ADJUVANT THERAPY; BREAST CARCINOMA; BREAST FIBROSIS; BREAST MALFORMATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DESQUAMATION; EDEMA; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FAT NECROSIS; HEMATOMA; HUMAN; INFECTION; INTERSTITIAL RADIATION; INTRAOPERATIVE RADIOTHERAPY; MASTALGIA; MASTECTOMY; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; RADIATION INJURY; RADIATION SICKNESS; RECURRENT CANCER; REVIEW; RIB FRACTURE; SEROMA; SKIN TOXICITY; SOCIOECONOMICS; SYSTEMATIC REVIEW; TELANGIECTASIA; WOUND COMPLICATION; WOUND INFECTION;

BRACHYTHERAPY; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RISK FACTORS;

EID: 58149260228     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.08.005     Document Type: Review

References (116)

1. Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: The Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol (2006) 17
2. Abe O., Abe R., Enomoto K., Kikuchi K., Koyama H., Masuda H., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
3. EBCTCG. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialist Collaborative Group. Lancet 2000;355:1757-1770.
4. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., Van Den Bogaert W., Barillot I., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
5. Bartelink H., Horiot J.C., Poortmans P.M., Struikmans H., Van Den Bogaert W., Fourquet A., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
6. Schnitt S.J., Hayman J., Gelman R., Eberlein T.J., Love S.M., Mayzel K., et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77 (1996) 1094-1100
7. Nattinger A.B., Kneusel R.T., Hoffmann R.G., and Gilligan M.A. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93 (2001) 1344-1346
8. Nattinger A.B., Hoffmann R.G., Kneusel R.T., and Schapira M.M. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356 (2000) 1148-1153
9. Virnig B, Habermann E, Al-Refaie M, Jensen E, and Tuttle T. Increased use of breast-conserving surgery: preferred treatment or failure to provide adequate local therapy? Breast Cancer Research and Treatment 106;2007. (abstract).
10. Holland R., Veling S.H.J., Mravunac M., and Hendriks J.H.C.L. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
11. Vaidya J.S., Vyas J.J., Chinoy R.F., Merchant N., Sharma O.P., and Mittra I. Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 74 (1996) 820-824
12. Faverly D.R.G., Hendriks J.H.C.L., and Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 91 (2001) 647-659
13. Frazier T.G., Wong R.W.Y., and Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 124 (1989) 37-38
14. Rosen P.P., Fracchia A.A., and Urban J.A. 'Residual' mammary carcinoma following simulated partial mastectomy. Cancer 35 (1975) 739-747
15. Veronesi U., Marubini E., Mariani L., Galimberti V., Luini A., Veronesi P., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
16. Fisher B., Anderson S., Redmond C.K., Wolmark N., Wickerham D.L., and Cronin W.M. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333 (1995) 1456-1461
17. Liljegren G., Holmberg L., Bergh J., Lindgren A., Tabār L., Nordgren H., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17 (1999) 2326-2333
18. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
19. Fyles A.W., McCready D.R., Manchul L.A., Trudeau M.E., Merante P., Pintilie M., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med (2004) 351
20. Malmstrom P., Holmberg L., Anderson H., Mattsson J., Svensson P.E., Tennvall-Nittby L., et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 39 (2003) 1690-1697
21. Winzer K.J., Sauer R., Sauerbrei W., Schneller E., Jaeger W., Braun M., et al. Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40 (2004) 998-1005
22. Holli K., Saaristo R., Isola J., Joensuu H., and Hakama M. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 84 (2001) 164-169
23. Touboul E., Buffat L., Mi Y., Lefranc J.P., Uzan S., Lhuillier P., et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43 (1999) 25-38
24. Freedman G.M., Anderson P.R., Hanlon A.L., Eisenberg D.F., and Nicolaou N. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 61 (2005) 1328-1336
25. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
26. Cook L.S., White E., Schwartz S.M., McKnight B., Daling J.R., and Weiss N.S. A population-based study of contralateral breast cancer following a first primary cancer (Washington, United States). Cancer Causes Control 7 (1996) 299-301
27. Yadav B.S., Sharma S.C., Patel F.D., Ghoshal S., and Kapoor R.K. Second primary in the contralateral breast after treatment of breast cancer. Radiother Oncol 86 (2008) 171-176
28. Chen Y., Thompson W., Semenciw R., and Mao Y. Epidemiology of the contralateral breast cancer. Cancer Epidemiol Biomark Prev 8 (1999) 855-861
29. Clark R.M., Whelan T., Levine M., Roberts R., Willan A., McCulloch P., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 88 (1996) 1659-1664
30. Mannino M, Yarnold J. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld. Radiother Oncol 2008; doi:10.1016/j.radonc.2008.05.002.
31. Arthur D.W., Koo D., Zwicker R.D., Tong S., Bear H.D., Kaplan B.J., et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 56 (2003) 681-689
32. Keisch M., Vicini F., Kuske R.R., Hebert M., White J., Quiet C., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
33. Baglan K.L., Sharpe M.B., Jaffray D., Frazier R.C., Fayad J., Kestin L.L., et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 55 (2003) 302-311
34. Vicini F., Winter K., Straube W., Wong J., Pass H., Rabinovitch R., et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63 (2005) 1531-1537
35. Orecchia R., and Veronesi U. Intraoperative electrons. Semin Radiat Oncol 15 (2005) 76-83
36. Veronesi U., Orecchia R., Luini A., Gatti G., Intra M., Zurrida S., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37 (2001) 2178-2183
37. Vaidya J.S., Tobias J.S., Baum M., Wenz F., Kraus-Tiefenbacher U., D'Souza D., et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol 15 (2005) 84-91
38. Bovi J., Qi X.S., White J., and Li X.A. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. Radiother Oncol 84 (2007) 226-232
39. Weed D.W., Edmundson G.K., Vicini F.A., Chen P.Y., and Martinez A.A. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy 4 (2005) 121-129
40. Patel R.R., Becker S.J., Das R.K., and Mackie T.R. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 935-942
41. Major T., Niehoff P., Kovacs G., Fodor J., and Polgar C. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer. Radiother Oncol 79 (2006) 321-328
42. Petersen R.P., Truong P.T., Kader H.A., Berthelet E., Lee J.C., Hilts M.L., et al. Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 69 (2007) 41-48
43. Weed D.W., Yan D., Martinez A.A., Vicini F.A., Wilkinson T.J., and Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 60 (2004) 484-492
44. Landis D.M., Luo W., Song J., Bellon J.R., Punglia R.S., Wong J.S., et al. Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavity. Int J Radiat Oncol Biol Phys 67 (2007) 1299-1308
45. Wong E.K., Truong P.T., Kader H.A., Nichol A.M., Salter L., Petersen R., et al. Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines. Int J Radiat Oncol Biol Phys 66 (2006) 372-376
46. White E.A., Cho J., Vallis K.A., Sharpe M.B., Lee G., Blackburn H., et al. Cone beam computed tomography guidance for setup of patients receiving accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 68 (2007) 547-554
47. Fatunase T., Zhiheng W., Yoo S., Hubbs J.L., Prosnitz R.G., Yin F., et al. Assessment of the residual error in soft tissue setup in patients undergoing partial breast irradiation: results of a prospective study using cone-beam computed tomography. Int J Radiat Oncol Biol Phys 70 (2008) 1025-1034
48. Overgaard M., Bentzen S.M., Christensen J.J., and Madsen E.H. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 9 (1987) 1-12
49. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
50. Guerrero M., and Li X. Analysis of a large number of clinical studies of breast cancer radiotherapy: estimation of radiobiological parameters. Phys Biol Med 48 (2003) 3307-3326
51. Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG, editor. Basic clinical radiobiology, 2nd ed. 2002.
52. Veronesi U., Gatti G., Luini A., Intra M., Orecchia R., Borgen P., et al. Intraoperative radiation therapy for breast cancer: technical notes. Breast J 9 (2003) 106-112
53. Suh W.W., Pierce L.J., Vicini F.A., and Hayman J.A. A cost comparison analysis of partial versus whole-breast irradiation after breast-conserving surgery for early-stage breast cancer. Int J Radiat Oncol Biol Phys 62 (2005) 790-796
54. Bartelink H. Intraoperative radiotherapy for breast cancer: tail wagging the dog?. Lancet Oncol 5 (2004) 207-208
55. Baglan K.L., Martinez A.A., Frazier R.C., Kini V.R., Kestin L.L., Chen P.Y., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 50 (2001) 1003-1011
56. Vicini F.A., Kestin L., Chen P., Benitez P., and Goldstein N.S. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95 (2003) 1205-1211
57. Benitez P.R., Chen P.Y., Vicini F.A., Wallace M., Kestin L., Edmundson G., et al. Surgical considerations in the treatment of early stage breast cancer with accelerated partial breast irradiation (APBI) in breast conserving therapy via interstitial brachytherapy. Am J Surg 188 (2004) 355-364
58. Chen P.Y., Vicini F.A., Benitez P., Kestin L.L., Wallace M., Mitchell C., et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106 (2006) 991-999
59. King T.A., Bolton J.S., Kuske R.R., Fuhrman G.M., Scroggins J., and Jiang X.Z. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg 180 (2000) 299-304
60. Kuske R.R., Winter K., Arthur D.W., Bolton J., Rabinovitch R., White J., et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 65 (2006) 45-51
61. Perera F., Yu E., Engel J., Holliday R., Scott L., Chisela F., et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 57 (2003) 1239-1246
62. Wazer D.E., Lowther D., Boyle T., Ulin K., Neuschatz A.R.R., and DiPetrillo T. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50 (2001) 107-111
63. Wazer D.E., Berle L., Graham R., Chung M., Rothschild J., Graves T., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53 (2002) 889-897
64. Wazer D.E., Kaufman S., Cuttino L., DiPetrillo T., and Arthur D.W. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64 (2006) 489-495
65. Lawenda B.D., Taghian A.G., Kachnic L.A., Hamdi H., Smith B.L., Gadd M.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56 (2003) 671-680
66. Kaufman S.A., DiPetrillo T.A., Price L.L., Midle J.B., and Wazer D.E. Long-term outcome and toxicity in a phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer. Brachytherapy 6 (2007) 286-292
67. Krishnan L., Jewell W.R., Tawfik O.W., and Krishnan E.C. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7 (2001) 91-96
68. Fentiman I.S., Poole C., Tong D., Winter P.J., Gregory W.M., Mayles H.M.O., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32 (1996) 608-611
69. Fentiman I.S., Poole C., Tong D., Winter P.J., Mayles H.M.O., Turner P., et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 27 (1991) 447-450
70. Fentiman I.S., Deshmane V., Tong D., Winter J., Mayles H., and Chaudary M.A. Caesium137 implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol 71 (2004) 281-285
71. Polgar C., Sulyok Z., Fodor J., Orosz Z., Major T., Takacsi-Nagy Z., et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80 (2002) 121-128
72. Polgar C., Major T., Fodor J., Nemeth G., Orosz Z., Sulyok Z., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
73. Polgar C., Fodor J., Major T., Nemeth G., Lovey K., Orosz Z., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 694-702
74. Lovey K., Fodor J., Major T., Szabo E., Orosz Z., Sulyok Z., et al. Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy-4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69 (2007) 724-731
75. Ott O.J., Hildebrandt G., Pötter R., Hammer J., Lotter M., Resch A., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial. Radiother Oncol 82 (2007) 281-286
76. Ott O.J., Lotter M., Sauer R., and Strnad V. Accelerated partial-breast irradiation with interstitial implants: the clinical relevance of the calculation of skin doses. Strahlenther Onkol 183 (2007) 426-431
77. Ott O.J., Pötter R., Hammer J., Hildebrandt G., Lotter M., Resch A., et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy: preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 180 (2004) 642-649
78. Ott O.J., Schulz-Wendtland R., Uter W., Pfahlberg A., Beckmann M.W., Sauer R., et al. Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer. Strahlenther Onkol 181 (2005) 638-644
79. Harris J.R., Levine M., Svensson G., and Hellman S. Analysis of the cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 5 (1979) 257-261
80. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
81. LENT SOMA tables. Radiother Oncol 1995;35:17-60.
82. Chao K.K., Vicini F.A., Wallace M., Mitchell C., Chen P., Ghilezan M., et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the William Beaumont hospital experience. Int J Radiat Oncol Biol Phys 69 (2007) 32-40
83. Zannis V., Beitsch P., Vicini F., Quiet C., Keleher A., Garcia D., et al. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 190 (2005) 530-538
84. Richards G.M., Berson A.M., Rescigno J., Sanghavi S., Siegel B., Axelrod D., et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 11 (2004) 739-746
85. Vicini F., Beitsch P., Quiet C., Keleher A., Garcia D., Snider H., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American society of breast surgeons MammoSite breast brachytherapy registry trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 (2008) 758-766
86. Vicini F.A., Beitsch P.D., Quiet C.A., Keleher A., Garcia D., Snider H.G., et al. First analysis of patient demographics, technical reproducibility, cosmesis and early toxicity: results of the American society of surgeons MammoSite breast brachytherapy registry trial. Cancer 104 (2005) 1138-1148
87. Sadeghi A., Prestidge B., Lee J., and Rosenthal A. Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite applicator. Brachytherapy 5 (2006) 230-234
88. Difronzo L.A., Tsai P.I., Hwang J.M., Lee J.J., Ryoo M.C., Rahimian J., et al. Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg 140 (2005) 787-794
89. Tsai P.I., Ryan M., Meek K., Ryoo M.C., Tome M., Takasugi J., et al. Accelerated partial breast irradiation using the MammoSite device: early technical experience and short-term clinical follow-up. Am Surg 72 (2006) 929-934
90. Chen S., Dickler A., Kirk M., Shah A., Jokich P., Solmos G., et al. Patterns of failure after MammoSite brachytherapy partial breast irradiation: a detailed analysis. Int J Radiat Oncol Biol Phys 69 (2007) 25-31
91. Dickler A., Kirk M.C., Choo J., Hsi W.C., Chu J., Dowlatshahi K., et al. Cosmetic outcome and incidence of infection with the MammoSite breast brachytherapy applicator. Breast J 11 (2005) 306-310
92. Harper J.L., Jenrette J.M., Vanek K.N., Aguero E.G., and Gillanders W.E. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61 (2005) 169-174
93. Shah N.M., Tenenholz T., Arthur D., DiPetrillo T., Bornstein B., Cardarelli G., et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101 (2004) 727-734
94. Evans S.B., Kaufman S.A., Price L.L., Cardarelli G., DiPetrillo T.A., and Wazer D.E. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing actors. Int J Radiat Oncol Biol Phys 65 (2006) 333-339
95. ® radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial. Radiother Oncol 79 (2006) 316-320
96. Niehoff P., Ballardini B., Polgar C., Major T., Hammer J., Richetti A., et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast 15 (2006) 319-325
97. Vicini F.A., Chen P., Wallace M., Mitchell C., Hasan Y., Grills I., et al. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 69 (2007) 1124-1130
98. Formenti S.C., Rosenstein B., Skinner K.A., and Jozsef G. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients - pilot feasibility study. Radiat Oncol 222 (2002) 171-178
99. Formenti S.C., Truong M.T., Goldberg J.D., Mukhi V., Rosenstein B., Roses D., et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 60 (2004) 493-504
100. Kozak K.R., Smith B.L., Adams J., Kornmehl E., Katz A., Gadd M., et al. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66 (2006) 691-698
101. Livi L., Paiar F., Banci Buonamici F., Scoccianti S., Meldolesi E., Scotti V., et al. Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. Tumori 91 (2005) 227-232
102. Leonard C., Carter D., Kercher J., Howell K., Henkenberns P., Tallhamer M., et al. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1291-1298
103. Ribeiro G.G., Magee B., Swindell R., Harris M., and Banerjee S.S. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 5 (1993) 278-283
104. Magee B., Swindell R., Harris M., and Banerjee S.S. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial. Radiother Oncol 39 (1996) 223-227
105. Luini A., Orecchia R., Gatti G., Intra M., Ciocca M., Galimberti V., et al. The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat 93 (2005) 55-59
106. Veronesi U., Orecchia R., Luini A., Galimberti V., Gatti G., Intra M., et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg 242 (2005) 101-106
107. Intra M., Gatti G., Luini A., Galimberti V., Veronesi P., Zurrida S., et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg 137 (2002) 737-740
108. Mussari S., la Sala W.S., Busana L., Vanoni V., Eccher C., Zani B., et al. Full-dose intraoperative radiotherapy with electrons in breast cancer: first report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 182 (2006) 589-595
109. Ollila D.W., Klauber-Demore N., Tesche L.J., Kuzmiak C.M., Pavic D., Goyal L.K., et al. Feasibility of breast preserving therapy with single fraction in situ radiotherapy delivered intraoperatively. Ann Surg Oncol 14 (2007) 660-669
110. Proulx G.M., Hurd T., Lee R.J., Stomper P.C., Podgorsak M.B., and Edge S.B. Intraoperative radiation therapy (IORT) to the tumor bed only for breast cancer: technique and outcome. Radiol Oncol (2001) 35
111. Vaidya J.S., Baum M., Tobias J.S., D'Souza D.P., Naidu S.V., Morgan S., et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12 (2001) 1075-1080
112. Veronesi U., Volterrani F., Luini A., Saccozzi R., Del Vecchio M., Zucali R., et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26 (1990) 671-673
113. Sarin R. Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Clin Pract Oncol 2 (2005) 40-47
114. McCormick B. Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. JNCCN 3 (2005) 301-307
115. Polgar C., Strnad V., and Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 15 (2005) 116-122
116. Orecchia R., Ciocca M., Tosi G., Franzetti S., Luini A., Gatti G., et al. Intraoperative electron beam radiotherapy (ELIOT) to the breast: a need for a quality assurance programme. Breast 14 (2005) 541-546